Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review
Ppublish 280 citations
Electronic publication date
April 10, 2009

View on Pubmed.gov 18940229 | View on doi.org 10.1016/j.pneur...

Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Search for publications in this journal Prog Neurobiol - 86(4):305-41

Abstract

Epigenetics and epigenomic medicine encompass a new science of brain and behavior that are already providing unique insights into the mechanisms underlying brain development, evolution, neuronal and network plasticity and homeostasis, senescence, the etiology of diverse neurological diseases and neural regenerative processes. Epigenetic mechanisms include DNA methylation, histone modifications, nucleosome repositioning, higher order chromatin remodeling, non-coding RNAs, and RNA and DNA editing. RNA is centrally involved in directing these processes, implying that the transcriptional state of the cell is the primary determinant of epigenetic memory. This transcriptional state can be modified not only by internal and external cues affecting gene expression and post-transcriptional processing, but also by RNA and DNA editing through activity-dependent intracellular transport and modulation of RNAs and RNA regulatory supercomplexes, and through trans-neuronal and systemic trafficking of functional RNA subclasses. These integrated processes promote dynamic reorganization of nuclear architecture and the genomic landscape to modulate functional gene and neural networks with complex temporal and spatial trajectories. Epigenetics represents the long sought after molecular interface mediating gene-environmental interactions during critical periods throughout the lifecycle. The discipline of environmental epigenomics has begun to identify combinatorial profiles of environmental stressors modulating the latency, initiation and progression of specific neurological disorders, and more selective disease biomarkers and graded molecular responses to emerging therapeutic interventions. Pharmacoepigenomic therapies will promote accelerated recovery of impaired and seemingly irrevocably lost cognitive, behavioral, sensorimotor functions through epigenetic reprogramming of endogenous regional neural stem cell fate decisions, targeted tissue remodeling and restoration of neural network integrity, plasticity and connectivity.

References

Neurobiol Dis. 2008 Mar;29(3):438-45

Cell. 2003 Dec 26;115(7):767-8

Nature. 2007 Dec 6;450(7171):903-7

Mol Cell. 2007 Aug 17;27(4):585-95

Cited by 280 citations (total)

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients.

Electronic publication date July 20, 2016

Search for publications in this journal Transl Psychiatry

A Topol [...] K J Brennand et al.

The genetic and epigenetic factors contributing to risk for schizophrenia (SZ) remain unresolved. Here we demonstrate, for the first time,...

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Epigenetics of sleep and chronobiology.

Electronic publication date October 3, 2014

Search for publications in this journal Curr Neurol Neurosci Rep

Irfan A Qureshi [...] Mark F Mehler et al.

The circadian clock choreographs fundamental biological rhythms. This system is comprised of the master circadian pacemaker in the suprachiasmatic nucleus...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties